These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 34319442

  • 21. Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.
    Wiley CA, Lopresti BJ, Venneti S, Price J, Klunk WE, DeKosky ST, Mathis CA.
    Arch Neurol; 2009 Jan; 66(1):60-7. PubMed ID: 19139300
    [Abstract] [Full Text] [Related]

  • 22. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.
    Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Någren K, Bullock R, Walker Z, Kennedy A, Fox NC, Rossor MN, Rinne JO, Brooks DJ.
    Neurology; 2009 Sep 08; 73(10):754-60. PubMed ID: 19587325
    [Abstract] [Full Text] [Related]

  • 23. Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer's disease.
    Hanseeuw BJ, Lopera F, Sperling RA, Norton DJ, Guzman-Velez E, Baena A, Pardilla-Delgado E, Schultz AP, Gatchel J, Jin D, Chen K, Reiman EM, Johnson KA, Quiroz YT.
    Alzheimers Res Ther; 2019 Feb 04; 11(1):17. PubMed ID: 30717814
    [Abstract] [Full Text] [Related]

  • 24. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.
    Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO.
    Neurology; 2007 May 08; 68(19):1603-6. PubMed ID: 17485647
    [Abstract] [Full Text] [Related]

  • 25. Amyloid deposition in early onset versus late onset Alzheimer's disease.
    Cho H, Seo SW, Kim JH, Suh MK, Lee JH, Choe YS, Lee KH, Kim JS, Kim GH, Noh Y, Ye BS, Kim HJ, Yoon CW, Chin J, Na DL.
    J Alzheimers Dis; 2013 May 08; 35(4):813-21. PubMed ID: 23507771
    [Abstract] [Full Text] [Related]

  • 26. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.
    Cohen AD, Price JC, Weissfeld LA, James J, Rosario BL, Bi W, Nebes RD, Saxton JA, Snitz BE, Aizenstein HA, Wolk DA, Dekosky ST, Mathis CA, Klunk WE.
    J Neurosci; 2009 Nov 25; 29(47):14770-8. PubMed ID: 19940172
    [Abstract] [Full Text] [Related]

  • 27. Regional correlations between [11C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort.
    Seo SW, Ayakta N, Grinberg LT, Villeneuve S, Lehmann M, Reed B, DeCarli C, Miller BL, Rosen HJ, Boxer AL, O'Neil JP, Jin LW, Seeley WW, Jagust WJ, Rabinovici GD.
    Neuroimage Clin; 2017 Nov 25; 13():130-137. PubMed ID: 27981028
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.
    Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A.
    Brain; 2011 Jan 25; 134(Pt 1):301-17. PubMed ID: 21149866
    [Abstract] [Full Text] [Related]

  • 30. Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.
    Mosconi L, Rinne JO, Tsui WH, Berti V, Li Y, Wang H, Murray J, Scheinin N, Någren K, Williams S, Glodzik L, De Santi S, Vallabhajosula S, de Leon MJ.
    Proc Natl Acad Sci U S A; 2010 Mar 30; 107(13):5949-54. PubMed ID: 20231448
    [Abstract] [Full Text] [Related]

  • 31. Positron emission tomography and neuropathologic estimates of fibrillar amyloid-β in a patient with Down syndrome and Alzheimer disease.
    Sabbagh MN, Fleisher A, Chen K, Rogers J, Berk C, Reiman E, Pontecorvo M, Mintun M, Skovronsky D, Jacobson SA, Sue LI, Liebsack C, Charney AS, Cole L, Belden C, Beach TG.
    Arch Neurol; 2011 Nov 30; 68(11):1461-6. PubMed ID: 22084131
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer's disease.
    Myers N, Pasquini L, Göttler J, Grimmer T, Koch K, Ortner M, Neitzel J, Mühlau M, Förster S, Kurz A, Förstl H, Zimmer C, Wohlschläger AM, Riedl V, Drzezga A, Sorg C.
    Brain; 2014 Jul 30; 137(Pt 7):2052-64. PubMed ID: 24771519
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET.
    La Joie R, Visani AV, Lesman-Segev OH, Baker SL, Edwards L, Iaccarino L, Soleimani-Meigooni DN, Mellinger T, Janabi M, Miller ZA, Perry DC, Pham J, Strom A, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD.
    Neurology; 2021 Feb 02; 96(5):e650-e661. PubMed ID: 33262228
    [Abstract] [Full Text] [Related]

  • 36. Local and distributed PiB accumulation associated with development of preclinical Alzheimer's disease.
    Brier MR, McCarthy JE, Benzinger TLS, Stern A, Su Y, Friedrichsen KA, Morris JC, Ances BM, Vlassenko AG.
    Neurobiol Aging; 2016 Feb 02; 38():104-111. PubMed ID: 26827648
    [Abstract] [Full Text] [Related]

  • 37. Pittsburgh compound B and the postmortem diagnosis of Alzheimer disease.
    Niedowicz DM, Beckett TL, Matveev S, Weidner AM, Baig I, Kryscio RJ, Mendiondo MS, LeVine H, Keller JN, Murphy MP.
    Ann Neurol; 2012 Oct 02; 72(4):564-70. PubMed ID: 23109151
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.